Regulatory Landscape Newsletter – September 2023

This is our Regulatory Landscape newsletter for September 2023 with our monthly insights on the evolving market for Regulatory professionals.   

For the month of August there were about 80 new Regulatory positions posted at smaller biotech and pharma companies in the US. This is up about 14% from last month and very similar to the number of postings for August 2022.  

About 68% of these positions were in Clinical Regulatory Strategy and 21% were in CMC Regulatory, 5% were in Advertising, Promotions & Labeling, and 4% in Regulatory Operations.  The majority of these roles were at Director level and above. There were only five new Regulatory VP/SVP positions posted in August.  

More than 60% of all postings were from companies in California or Massachusetts.  About 22% of all new Regulatory roles in August were posted as Remote and about 27% were Hybrid (remote/onsite). It appears that the number of purely remote Regulatory roles is trending down while the number of hybrid positions has been on the rise.  There were layoffs announced at 24 biotech and pharma companies in August – which is similar to the number we saw in July.    

This month we are helping our client to fill the following roles:
  –  Regulatory Affairs Executive Director – SF Bay Area or Boston Area
  –  Regulatory Affairs Associate Director (Ex-US) – Remote
  –  Regulatory Affairs Strategy Director or AD – Boston Area 

You can see these job descriptions on our website at

We are currently representing an exceptional Regulatory leader who is immediately available for full time VP/SVP roles and also Regulatory Consulting engagements.  Let me know if you are interested in learning more about this individual and we can discuss their background.

Please keep us in mind if you need assistance with your Regulatory hiring or let us know if you are open to making a career move soon.